St. Helier, Jersey, the Channel Islands - January 9, 2013, St. Helier, Jersey, the Channel Islands - Novocure Limited, an oncology company, announced the appointment of Louis J. Lavigne Jr., James T. Lenehan, Robert J. Mylod Jr. and Charles G. Phillips III to its board of directors.
Article continues below
Mr. Lavigne Jr. is currently Managing Director of Lavrite, LLC, a management consulting firm. Mr. Lavigne retired in March 2005 as Executive Vice President and Chief Financial Officer of Genentech, Inc. He currently serves on the boards of BMC Software, Inc., Accuray Inc., SafeNet, Inc. and Allergan, Inc., and is a member of Deloitte's Life Sciences Advisory Board. He also serves as a trustee of the California Institute of Technology (CalTech), Babson College and Babson Global and Children's Hospital Oakland.
Mr. Lenehan served in a variety of positions at Johnson & Johnson from October 1976 until he retired as President and Vice Chairman in June 2004. During his 28-year tenure with Johnson & Johnson, Mr. Lenehan held executive positions including President of McNeil Consumer Products Company, Worldwide Chairman, Medical Devices and Diagnostics Group and Worldwide Chairman, Consumer Pharmaceuticals & Professional Group. He is a member of the board of directors of
Medtronic Inc.
Mr. Mylod Jr. served as Vice Chairman and Head of Worldwide Strategy and Planning at priceline.com from January 2009 to March 2011. Prior to being named Vice Chairman, Mr. Mylod served as priceline.com’s Chief Financial Officer from November 2000. Before joining priceline.com, Mr. Mylod was a Principal at Stonington Partners, a private equity investment firm. Mr. Mylod also serves on the board of directors of EverBank Financial Corp.
Mr. Phillips III served as Chief Operating Officer of Prentice Capital Management, LLC, an investment management firm, from 2005 until his retirement in 2008. Mr. Phillips was previously a managing director from 1991 to 2002 and President from 1998 to 2001 of Gleacher & Co., and its successor, Gleacher NatWest, an investment bank specializing in mergers and acquisition and direct private investment. ■